inquiri
relationship
viral
respiratori
ill
incept
exacerb
asthma
facilit
recent
advanc
research
approach
technolog
articl
identifi
import
knowledg
gap
futur
research
question
discuss
new
investig
tool
includ
improv
respiratori
viru
detect
techniqu
permit
current
futur
research
defin
relationship
host
viru
development
environment
mechan
regul
better
understand
process
facilit
develop
improv
strategi
prevent
treatment
virusinduc
wheez
ill
asthma
exacerb
possibl
ultim
goal
discov
effect
approach
primari
prevent
asthma
centuri
physician
mose
maimonid
state
refer
asthma
conclud
disord
start
common
cold
especi
raini
season
patient
forc
gasp
breath
day
night
depend
durat
onset
phlegm
expel
flow
complet
lung
well
clear
thu
physician
long
recogn
associ
common
respiratori
ill
onset
andor
worsen
wheez
asthma
recent
year
howev
research
seek
gain
mechanist
understand
natur
rel
import
associ
limit
number
tool
diagnos
viral
infect
investig
relationship
acut
chronic
effect
asthma
articl
discuss
recent
advanc
research
approach
technolog
help
defin
associ
viral
respiratori
ill
develop
wheez
ill
childhood
asthma
well
asthma
exacerb
children
adult
addit
identifi
import
gap
current
knowledg
reflect
potenti
direct
futur
research
understand
role
viral
respiratori
infect
asthma
advanc
respiratori
viru
detect
led
critic
new
insight
develop
exacerb
asthma
exampl
past
respiratori
virus
difficult
detect
convent
method
grow
well
cultur
clinic
studi
acut
viral
ill
detect
rate
norm
use
techniqu
viral
cultur
antigen
detect
use
label
antibodi
serolog
detect
recent
molecular
techniqu
greatli
improv
overal
rate
viral
detect
tabl
studi
acut
respiratori
ill
report
viral
detect
rate
high
especi
infant
techniqu
use
identifi
whole
new
class
virus
metapneumovirus
bocavirus
new
strain
coronavirus
sar
polyomavirus
virus
may
caus
acut
wheez
infanc
also
associ
acut
exacerb
asthma
addit
recent
report
use
molecular
detect
techniqu
partial
full
sequenc
analysi
identifi
novel
speci
human
rhinovirus
hrv
design
hrvc
also
call
hrvni
hrvqpm
hrvx
novel
group
hrvc
contribut
signific
burden
hrvrelat
ill
may
particularli
relev
infant
wheez
establish
asthma
seem
like
hrvc
circul
time
rather
newli
emerg
viru
recent
data
studi
children
suggest
virus
hrvc
group
may
either
prone
stimul
acut
symptom
asthma
intrins
one
common
featur
hrvc
newli
identifi
virus
difficult
imposs
grow
standard
tissu
cultur
explain
detect
first
molecular
techniqu
caveat
regard
dramat
improv
pcrbase
method
viral
detect
increas
sensit
detect
viral
genet
materi
host
presenc
pathogen
respiratori
secret
necessarili
associ
clinic
ill
particularli
true
hrv
found
consider
proport
healthi
individu
especi
spring
fall
studi
util
sequenti
sampl
children
indic
detect
hrv
well
children
repres
asymptomat
infect
therefor
import
link
symptomat
ill
particularli
wheez
ill
hrv
detect
estim
role
determin
asthma
risk
chronic
infect
hrv
occur
except
associ
mark
immunosuppress
identif
biomark
would
allow
us
better
connect
viral
detect
clinic
relev
outcom
import
research
goal
would
improv
abil
interpret
epidemiolog
data
use
viral
sequenc
track
individu
strain
clinic
studi
develop
new
techniqu
track
anatom
distribut
virus
vivo
could
aid
understand
issu
burden
health
care
cost
associ
hospit
emerg
room
visit
virusinduc
wheez
first
three
year
life
signific
develop
specif
therapi
huge
unmet
medic
need
virusinduc
wheez
infanc
associ
increas
risk
recurr
wheez
children
grow
older
moreov
substanti
evid
earli
life
virusinduc
wheez
ill
associ
subsequ
childhood
asthma
import
note
fundament
question
whether
viral
respiratori
infect
causal
factor
instead
serv
indic
predisposit
asthma
still
unresolv
two
recent
studi
readdress
controversi
respiratori
syncyti
viru
rsv
frequent
infect
caus
bronchiol
pneumonia
children
year
age
younger
commonli
present
wheez
ill
late
fall
winter
earli
spring
temper
climat
recent
wu
colleagu
report
time
infant
birth
relationship
peak
bronchiol
hospit
winter
season
predict
likelihood
develop
clinic
signific
addit
children
day
old
winter
viru
peak
also
greatest
risk
develop
asthma
similarli
season
epidemiolog
analysi
use
demonstr
infantil
wheez
ill
hrv
season
import
predictor
develop
persist
wheez
asthma
later
studi
suggest
possibl
respiratori
viru
infect
earli
childhood
contribut
asthma
causal
anoth
recent
studi
reach
opposit
conclus
thomsen
colleagu
investig
relationship
rsv
infect
requir
hospit
develop
asthma
appli
genet
varianc
direct
causat
model
larg
twin
registri
denmark
base
work
author
conclud
rsv
infect
sever
enough
result
hospit
indic
genet
predisposit
rather
causal
factor
asthma
appar
dispar
inform
high
qualiti
studi
regard
direct
causat
sever
rsv
infect
asthma
suggest
resolv
controversi
may
requir
prospect
random
placebocontrol
intervent
studi
eg
use
prophylact
rsvspecif
monoclon
antibodi
therapi
incorpor
improv
viral
diagnost
longterm
studi
suggest
type
viru
caus
wheez
ill
could
signific
indic
asthma
risk
exampl
evid
sever
studi
wheez
ill
hrv
may
associ
especi
high
risk
subsequ
childhood
asthma
especi
children
earli
clinic
laboratori
indic
research
need
determin
whether
virus
eg
parainfluenza
virus
metapneumoviru
coronavirus
bocavirus
adenovirus
influenza
virus
differ
capac
influenc
develop
asthma
extent
viral
infect
alon
impart
increas
risk
wheez
infanc
whether
allergen
sensit
exposur
earli
childhood
critic
determin
respons
infect
develop
asthma
import
question
underli
current
research
effort
regard
role
host
factor
asthma
onset
hypothesi
varieti
host
factor
mani
govern
host
genet
influenc
risk
virusinduc
wheez
earli
life
subsequ
develop
childhood
asthma
import
understand
host
factor
modifi
relationship
earli
life
viral
respiratori
infect
develop
wheez
ill
childhood
asthma
identifi
risk
factor
determin
infant
young
children
like
wheez
infect
role
infect
genesi
asthma
focu
intens
investig
regard
rel
import
lower
lung
volum
birth
especi
born
prematur
atop
statu
infant
intens
mucu
secret
respons
infect
neurotroph
pathway
critic
airway
hyperrespons
provok
infect
abil
infant
wheez
gener
immun
respons
viral
pathogen
includ
product
type
iii
interferon
remain
import
area
research
overal
import
identifi
host
genet
factor
influenc
develop
pulmonari
immun
system
matur
delay
host
airway
antivir
respons
could
increas
risk
develop
virusinduc
wheez
childhood
asthma
differ
matur
level
airway
immun
system
could
render
infant
children
suscept
develop
respiratori
virusiniti
persist
airway
sequela
altern
possibl
virusinduc
wheez
episod
may
marker
individu
predispos
asthma
delay
airway
immun
system
develop
investig
host
factor
nutrit
statu
respons
medic
also
prioriti
notabl
sever
studi
link
vitamin
statu
risk
develop
asthma
also
suscept
infecti
respiratori
ill
addit
associ
acetaminophen
use
increas
risk
childhood
asthma
onset
report
confound
factor
drug
use
fever
reduct
childhood
viral
respiratori
infect
random
control
clinic
trial
would
need
defin
risk
also
would
use
determin
whether
differenti
host
respons
acetaminophen
could
modifi
potenti
risk
year
age
viral
respiratori
infect
allergi
synergist
increas
risk
acut
wheez
exacerb
childhood
asthma
extent
allerg
inflamm
alter
innat
antivir
respons
airway
epithelium
also
signific
interest
use
anim
model
vitro
experi
experiment
challeng
hrv
virus
provid
addit
mechanist
insight
interact
viral
infect
respiratori
allergi
promis
area
investig
involv
examin
immun
system
mediat
pathway
intersect
allergenand
virusinduc
inflammatori
respons
eg
thymic
stromal
lymphopoietin
tolllik
receptor
pathway
recent
evid
point
impair
innat
interferon
respons
airway
asthmat
subject
risk
factor
asthma
exacerb
although
controversi
find
renew
interest
whether
host
variat
rna
sens
pathway
eg
tolllik
receptor
rigi
affect
ill
outcom
perhap
asthma
dna
virus
bocavirus
also
caus
wheez
ill
indic
variat
dna
sens
pathway
eg
tolllik
receptor
dna
protein
kinas
also
consid
whether
genet
polymorph
dna
rna
sens
pathway
affect
host
respons
respiratori
virus
need
address
differ
phenotyp
asthma
may
differ
mechan
suscept
virusinduc
exacerb
brittl
asthma
sever
asthma
nonatop
asthma
refractori
asthma
frequent
exacerb
distinct
asthma
phenotyp
may
possess
uniqu
mechan
suscept
virusinduc
exacerb
addit
recurr
exacerb
may
alter
natur
histori
asthma
acceler
loss
lung
function
addit
host
factor
could
alter
suscept
asthmat
subject
virusinduc
exacerb
includ
age
gender
nutrit
smoke
stress
concomit
diseas
may
affect
innat
adapt
immun
system
viral
strain
make
differ
relat
develop
wheez
ill
asthma
risk
exacerb
hrv
princip
trigger
asthma
exacerb
age
canon
serotyp
mani
new
strain
hrvc
genom
singl
strand
rna
base
rna
polymeras
high
error
rate
approxim
base
may
contribut
hrv
sequenc
variabl
hrv
infect
caus
asthma
exacerb
associ
asthma
onset
young
children
tempt
hypothes
certain
strain
asthmagen
accordingli
recent
studi
murin
model
shown
differ
isol
rsv
vari
significantli
regard
virul
mucogen
case
hrv
target
vaccin
hrv
strain
could
possibl
help
prevent
exacerb
even
prevent
develop
asthma
determin
pathogen
factor
virul
strain
could
provid
new
target
antivir
therapi
given
evid
show
associ
viral
respiratori
infect
earli
life
subsequ
develop
asthma
understand
role
environment
influenc
infanc
may
outcom
infect
repres
import
area
futur
investig
factor
consid
would
includ
manner
earli
life
exposur
environment
factor
allergen
microbi
flora
air
pollut
may
influenc
develop
immun
system
lung
modul
subsequ
respons
viral
respiratori
infect
studi
determin
advers
effect
air
pollut
eg
environment
tobacco
smoke
ozon
diesel
fuel
exhaust
asthmat
airway
highlight
complex
tri
understand
pathogenesi
persist
asthma
exacerb
children
adult
extent
environment
exposur
interact
airway
inflamm
initi
respiratori
tract
infect
andor
allergen
exposur
mechan
involv
need
investig
studi
evalu
concurr
person
exposur
differ
risk
factor
interact
need
environom
ie
synchron
evalu
differ
environment
well
genet
factor
may
abl
help
individu
treatment
taken
togeth
studi
could
direct
develop
new
therapeut
eg
antivir
antiinflammatori
identifi
target
popul
asthmat
children
adult
benefit
new
exist
treatment
strategi
although
virus
bacteria
usual
consid
separ
possibl
bacteria
interact
respiratori
cold
virus
alter
outcom
respiratori
infect
asthmat
individu
howev
littl
known
role
secondari
bacteri
infect
increas
sever
persist
symptom
recent
knowledg
microb
restrict
cultur
organ
new
molecular
tool
microarray
develop
detect
practic
known
virus
bacteria
includ
thousand
organ
previous
unknown
evolv
technolog
bioinformat
tool
use
studi
airway
microbiom
better
understand
airway
microbiom
includ
interact
microorgan
respiratori
virus
may
shed
new
light
develop
asthma
pathogenesi
asthma
exacerb
possibl
specif
pattern
infect
andor
colon
modifi
airway
develop
physiolog
risk
asthma
fact
recent
evid
establish
intestin
flora
infant
contribut
immun
develop
process
may
influenc
develop
allerg
diseas
perhap
qualiti
antivir
respons
studi
microbi
flora
gut
skin
respiratori
tract
provid
new
insight
relationship
perhap
provid
anoth
strategi
prevent
allerg
diseas
asthma
best
way
determin
whether
viral
lower
respiratori
tract
infect
infanc
caus
asthma
would
perform
clinic
trial
use
effect
antivir
intervent
given
prophylact
current
approv
vaccin
rsv
hrv
could
use
studi
howev
result
two
nonrandom
studi
passiv
immun
rsv
earli
life
suggest
prevent
sever
rsv
infect
infanc
use
monoclon
antibodi
might
reduc
subsequ
asthma
howev
random
placebocontrol
studi
design
need
definit
answer
question
similar
studi
respiratori
virus
hrv
await
develop
safe
effect
antivir
vaccin
high
rate
exposur
virus
earli
life
rel
immatur
neonat
immun
system
make
effect
vaccin
difficult
requir
develop
novel
vaccin
strategi
technolog
safe
antivir
agent
may
eventu
becom
import
antibiot
chang
microbiolog
landscap
associ
respiratori
morbid
varieti
novel
therapeut
includ
inhibitor
attach
host
cell
viral
proteas
inhibitor
inhibitor
viral
replic
variou
stage
develop
howev
sever
challeng
approach
sinc
time
onset
cold
symptom
deterior
lung
function
short
develop
viral
resist
must
consid
specif
antivir
therapi
implement
clinic
practic
also
may
necessari
develop
accur
afford
rapid
viral
diagnost
viral
diagnost
may
need
period
one
viru
especi
preval
eg
fall
hrv
infect
specif
viral
syndrom
readili
recogniz
eg
influenzalik
ill
januari
broadspectrum
antivir
agent
develop
notwithstand
potenti
new
therapi
consider
improv
may
result
optim
current
avail
one
treatment
antiinflammatori
drug
inhal
corticosteroid
leukotrien
antagonist
reduc
risk
exacerb
suggest
moder
inflamm
may
reduc
chanc
cold
precipit
bronchospasm
mechan
reduct
risk
known
explor
may
lead
new
treatment
prevent
exacerb
exampl
possibl
mechan
includ
reduct
number
inflammatori
cell
could
amplifi
respons
viru
infect
regener
airway
epitheli
barrier
remov
chronic
epitheli
damag
caus
product
allerg
inflamm
restor
normal
epitheli
innat
immun
alter
allerg
inflammatori
mediat
addit
research
need
determin
effect
current
asthma
control
virusinduc
exacerb
viral
respiratori
infect
allergen
exposur
allergensensit
individu
may
combin
increas
risk
asthma
exacerb
therapi
target
allerg
airway
inflamm
antiig
treatment
may
promis
allerg
individu
prone
virusinduc
exacerb
also
macrolid
deserv
attent
possibl
antiinflammatori
agent
target
exacerb
pharmacogenet
expect
offer
person
solut
futur
current
mani
attempt
character
asthma
phenotyp
clinic
sens
use
among
criteria
virusinduc
exacerb
key
compon
consequ
possibl
intervent
tailor
specif
phenotyp
notabl
recent
placebocontrol
trial
suggest
neither
highdos
inhal
oral
corticosteroid
suitabl
virusinduc
wheez
infanc
possibl
asthma
control
could
benefit
specif
subset
infant
studi
design
evalu
individu
respons
control
medic
highlight
differenti
treatment
respons
among
issu
continu
versu
ondemand
pharmacotherapi
exacerb
reevalu
differ
asthma
phenotyp
recent
effort
perform
comprehens
studi
investig
immunolog
virolog
physiolog
measur
lower
airway
asthmat
individu
viral
infect
help
inform
develop
target
therapeut
strategi
strategi
aim
reduct
respiratori
viru
exposur
achiev
simpl
mean
hand
wash
signific
impact
morbid
suggest
need
includ
focus
educ
program
part
exacerb
manag
rodent
model
infect
respiratori
virus
parainfluenza
sendai
viru
rsv
provid
great
insight
cellular
immun
respons
infect
potenti
mechan
relat
viral
infect
young
anim
longterm
chang
lung
structur
function
recent
rodent
model
infect
hrv
relat
picornaviru
mengoviru
develop
may
help
explor
area
hrv
biolog
difficult
evalu
either
vitro
clinic
model
studi
need
character
detail
innat
epitheli
respons
viral
infect
differ
condit
explor
effect
infecti
outcom
cofactor
allerg
inflamm
epitheli
damag
pollut
studi
differenti
human
epithelium
organ
cultur
lung
sinu
tissu
may
help
experi
final
continu
advanc
microarray
technolog
genomewid
associ
studi
system
biolog
highthroughput
technolog
provid
import
avenu
futur
investig
import
gap
remain
current
knowledg
regard
role
respiratori
viru
infect
incept
exacerb
asthma
tabl
ii
clear
recent
advanc
investigatori
tool
approach
begin
allow
investig
make
import
inroad
toward
discern
complex
interplay
host
viral
development
environment
factor
process
defin
process
potenti
provid
mechanist
foundat
develop
new
effect
approach
prevent
treatment
virusinduc
wheez
ill
asthma
exacerb
well
longer
term
goal
develop
effect
strategi
primari
prevent
asthma
requir
sequenc
inform
synthes
primer
probe
target
virus
extrem
sensit
detect
littl
one
copi
genom
